condition found
Source: |
Type: |
Cognitive |
236- | AL,  |   | Allicin: Chemistry and Biological Properties |
- | Analysis, | NA, | NA |
2558- | AL,  |   | Allicin, an Antioxidant and Neuroprotective Agent, Ameliorates Cognitive Impairment |
- | Review, | AD, | NA |
2657- | AL,  |   | Allicin pharmacology: Common molecular mechanisms against neuroinflammation and cardiovascular diseases |
- | Review, | CardioV, | NA | - | Review, | AD, | NA |
2660- | AL,  |   | Allicin: A review of its important pharmacological activities |
- | Review, | AD, | NA | - | Review, | Var, | NA | - | Review, | Park, | NA | - | Review, | Stroke, | NA |
3444- | ALA,  |   | Alpha-Lipoic Acid Nootropic Review: Benefits, Use, Dosage & Side Effects |
- | Review, | NA, | NA |
3443- | ALA,  |   | Molecular and Therapeutic Insights of Alpha-Lipoic Acid as a Potential Molecule for Disease Prevention |
- | Review, | Var, | NA | - | Review, | AD, | NA |
3438- | ALA,  |   | The Potent Antioxidant Alpha Lipoic Acid |
- | Review, | NA, | NA | - | Review, | AD, | NA |
3447- | ALA,  |   | Redox Active α-Lipoic Acid Differentially Improves Mitochondrial Dysfunction in a Cellular Model of Alzheimer and Its Control Cells |
- | in-vitro, | AD, | SH-SY5Y |
3539- | ALA,  |   | Alpha-lipoic acid as a dietary supplement: Molecular mechanisms and therapeutic potential |
- | Review, | AD, | NA |
3543- | ALA,  |   | The Effect of Lipoic Acid Therapy on Cognitive Functioning in Patients with Alzheimer's Disease |
- | Study, | AD, | NA |
3544- | ALA,  |   | Alpha lipoic acid for dementia |
- | Review, | AD, | NA |
3545- | ALA,  |   | Potential therapeutic effects of alpha lipoic acid in memory disorders |
- | Review, | AD, | NA |
3272- | ALA,  |   | Alpha-lipoic acid as a dietary supplement: Molecular mechanisms and therapeutic potential |
- | Review, | AD, | NA |
3271- | ALA,  |   | Decrypting the potential role of α-lipoic acid in Alzheimer's disease |
- | Review, | AD, | NA |
3270- | ALA,  |   | Alpha-lipoic acid as a new treatment option for Alzheimer's disease--a 48 months follow-up analysis |
- | Trial, | AD, | NA |
3269- | ALA,  |   | Sulfur-containing therapeutics in the treatment of Alzheimer’s disease |
- | NA, | AD, | NA |
3547- | ALA,  |   | Potential Therapeutic Effects of Lipoic Acid on Memory Deficits Related to Aging and Neurodegeneration |
- | Review, | AD, | NA | - | Review, | Park, | NA |
3549- | ALA,  |   | Important roles of linoleic acid and α-linolenic acid in regulating cognitive impairment and neuropsychiatric issues in metabolic-related dementia |
- | Review, | AD, | NA |
3550- | ALA,  |   | Mitochondrial Dysfunction and Alpha-Lipoic Acid: Beneficial or Harmful in Alzheimer's Disease? |
- | Review, | AD, | NA |
3551- | ALA,  |   | Alpha lipoic acid treatment in late middle age improves cognitive function: Proteomic analysis of the protective mechanisms in the hippocampus |
- | in-vivo, | AD, | NA |
3552- | ALA,  |   | The dietary fatty acids α-linolenic acid (ALA) and linoleic acid (LA) selectively inhibit microglial nitric oxide production |
- | in-vitro, | AD, | BV2 |
3546- | ALA,  |   | Cognitive and Mood Effect of Alpha-Lipoic Acid Supplementation in a Nonclinical Elder Sample: An Open-Label Pilot Study |
- | Study, | AD, | NA |
3159- | Ash,  |   | Neuroprotective effects of Withania somnifera in the SH-SY5Y Parkinson cell model |
- | in-vitro, | Park, | SH-SY5Y |
2605- | Ba,  | BA,  |   | Potential therapeutic effects of baicalin and baicalein |
- | Review, | Var, | NA | - | Review, | Stroke, | NA | - | Review, | IBD, | NA | - | Review, | Arthritis, | NA | - | Review, | AD, | NA | - | Review, | Park, | NA |
2626- | Ba,  |   | Molecular targets and therapeutic potential of baicalein: a review |
- | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | Stroke, | NA |
2679- | BBR,  |   | Berberine Improves Behavioral and Cognitive Deficits in a Mouse Model of Alzheimer’s Disease via Regulation of β-Amyloid Production and Endoplasmic Reticulum Stress |
- | in-vivo, | AD, | NA |
2731- | BetA,  |   | Betulinic Acid for Glioblastoma Treatment: Reality, Challenges and Perspectives |
- | Review, | GBM, | NA | - | Review, | Park, | NA | - | Review, | AD, | NA |
760- | Bor,  |   | Therapeutic Efficacy of Boric Acid Treatment on Brain Tissue and Cognitive Functions in Rats with Experimental Alzheimer’s Disease |
- | in-vivo, | AD, | NA |
696- | Bor,  |   | Nothing Boring About Boron |
- | Review, | Var, | NA |
3518- | Bor,  |   | Boron Report |
- | Review, | Var, | NA | - | Review, | AD, | NA |
2775- | Bos,  |   | The journey of boswellic acids from synthesis to pharmacological activities |
- | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | PSA, | NA |
2772- | Bos,  |   | Mechanistic role of boswellic acids in Alzheimer’s disease: Emphasis on anti-inflammatory properties |
- | Review, | AD, | NA |
2768- | Bos,  |   | Boswellic acids as promising agents for the management of brain diseases |
- | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | Park, | NA |
2782- | CHr,  |   | Broad-Spectrum Preclinical Antitumor Activity of Chrysin: Current Trends and Future Perspectives |
- | Review, | Var, | NA | - | Review, | Stroke, | NA | - | Review, | Park, | NA |
1567- | Cin,  |   | Cinnamon: Mystic powers of a minute ingredient |
- | Review, | Var, | NA |
- | Review, | AD, | NA |
2816- | CUR,  |   | NEUROPROTECTIVE EFFECTS OF CURCUMIN |
- | Review, | AD, | NA | - | Review, | Park, | NA |
2688- | CUR,  |   | Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs |
- | Review, | Var, | NA | - | Review, | AD, | NA |
3576- | CUR,  |   | Protective Effects of Indian Spice Curcumin Against Amyloid-β in Alzheimer's Disease |
- | Review, | AD, | NA |
3574- | CUR,  |   | The effect of curcumin (turmeric) on Alzheimer's disease: An overview |
- | Review, | AD, | NA |
2272- | dietMet,  |   | Methionine restriction - Association with redox homeostasis and implications on aging and diseases |
- | Review, | Nor, | NA |
3232- | EGCG,  |   | (−)-Epigallocatechin-3-gallate attenuates cognitive deterioration in Alzheimer׳s disease model mice by upregulating neprilysin expression |
- | in-vivo, | AD, | NA |
3237- | EGCG,  |   | (-)-Epigallocatechin-3-gallate attenuates cognitive deterioration in Alzheimer's disease model mice by upregulating neprilysin expression |
- | in-vivo, | AD, | NA |
2153- | Ex,  |   | The Impact of Exercise on Cancer Mortality, Recurrence, and Treatment-Related Adverse Effects |
- | Review, | Var, | NA |
2861- | FIS,  |   | The neuroprotective effects of fisetin, a natural flavonoid in neurodegenerative diseases: Focus on the role of oxidative stress |
- | Review, | Nor, | NA | - | Review, | Stroke, | NA | - | Review, | Park, | NA |
2521- | H2,  |   | Oxyhydrogen Gas: A Promising Therapeutic Approach for Lung, Breast and Colorectal Cancer |
- | Review, | CRC, | NA | - | Review, | Lung, | NA | - | Review, | BC, | NA |
2869- | HNK,  |   | Nature's neuroprotector: Honokiol and its promise for Alzheimer's and Parkinson's |
- | Review, | AD, | NA | - | Review, | Park, | NA |
2872- | HNK,  |   | Honokiol alleviated neurodegeneration by reducing oxidative stress and improving mitochondrial function in mutant SOD1 cellular and mouse models of amyotrophic lateral sclerosis |
- | in-vivo, | ALS, | NA | - | NA, | Stroke, | NA | - | NA, | AD, | NA | - | NA, | Park, | NA |
3268- | Lyco,  |   | Lycopene as a Natural Antioxidant Used to Prevent Human Health Disorders |
- | Review, | AD, | NA |
2540- | M-Blu,  |   | Alternative mitochondrial electron transfer for the treatment of neurodegenerative diseases and cancers: Methylene blue connects the dots |
- | Review, | Var, | NA | - | Review, | AD, | NA |
204- | MFrot,  |   | Rotating magnetic field improved cognitive and memory impairments in a sporadic ad model of mice by regulating microglial polarization |
- | in-vivo, | AD, | NA |
185- | MFrot,  |   | Case Report: End-Stage Recurrent Glioblastoma Treated With a New Noninvasive Non-Contact Oncomagnetic Device |
- | Human, | GBM, | NA |
212- | MFrot,  |   | Rotating magnetic field inhibits Aβ protein aggregation and alleviates cognitive impairment in Alzheimer’s disease mice |
- | in-vivo, | AD, | SH-SY5Y |
3489- | MFrot,  |   | Rotating magnetic field inhibits Aβ protein aggregation and alleviates cognitive impairment in Alzheimer's disease mice. |
- | in-vivo, | AD, | NA |
3488- | MFrot,  |   | Rotating magnetic field improves cognitive and memory impairments in APP/PS1 mice by activating autophagy and inhibiting the PI3K/AKT/mTOR signaling pathway |
- | in-vivo, | AD, | NA |
3567- | MFrot,  |   | The Effect of Extremely Low-Frequency Magnetic Field on Stroke Patients: A Systematic Review |
- | Review, | Stroke, | NA |
2484- | mushLions,  |   | Neurotrophic and Neuroprotective Effects of Hericium erinaceus |
- | Review, | Stroke, | NA | - | Review, | AD, | NA | - | Review, | Park, | NA |
2933- | NAD,  |   | Nicotinamide mononucleotide (NMN) as an anti-aging health product – Promises and safety concerns |
- | Review, | Nor, | NA | - | NA, | AD, | NA | - | NA, | Diabetic, | NA | - | NA, | Stroke, | NA | - | NA, | LiverDam, | NA | - | NA, | Park, | NA |
2032- | PB,  |   | Phenylbutyric acid reduces amyloid plaques and rescues cognitive behavior in AD transgenic mice |
- | in-vivo, | AD, | NA |
3249- | PBG,  |   | Can Propolis Be a Useful Adjuvant in Brain and Neurological Disorders and Injuries? A Systematic Scoping Review of the Latest Experimental Evidence |
- | Review, | Var, | NA |
2963- | PL,  |   | Piperlongumine activates Sirtuin1 and improves cognitive function in a murine model of Alzheimer’s disease |
- | in-vitro, | AD, | HEK293 |
3347- | QC,  |   | Recent Advances in Potential Health Benefits of Quercetin |
- | Review, | Var, | NA | - | Review, | AD, | NA |
3367- | QC,  |   | Targeting Nrf2 signaling pathway by quercetin in the prevention and treatment of neurological disorders: An overview and update on new developments |
- | Review, | Stroke, | NA | - | Review, | AD, | NA |
3336- | QC,  |   | Neuroprotective Effects of Quercetin in Alzheimer’s Disease |
- | Review, | AD, | NA |
3100- | RES,  |   | Neuroprotective effects of resveratrol in Alzheimer disease pathology |
- | Review, | AD, | NA |
3099- | RES,  |   | Resveratrol and cognitive decline: a clinician perspective |
- | Review, | Nor, | NA | - | NA, | AD, | NA |
3490- | RF,  |   | Multidimensional insights into the repeated electromagnetic field stimulation and biosystems interaction in aging and age-related diseases |
- | Review, | AD, | NA | - | Review, | Park, | NA |
3461- | RF,  |   | Electromagnetic Field Stimulation Therapy for Alzheimer’s Disease |
- | Review, | AD, | NA |
3020- | RosA,  |   | Protective Effect of Rosmarinic Acid on Endotoxin-Induced Neuronal Damage Through Modulating GRP78/PERK/MANF Pathway |
- | in-vivo, | Nor, | NA | - | in-vitro, | NA, | SH-SY5Y |
3022- | RosA,  |   | Rosmarinic acid against cognitive impairment via RACK1/HIF-1α regulated microglial polarization in sepsis-surviving mice |
- | in-vitro, | Sepsis, | NA |
1452- | SFN,  |   | Sulforaphane Suppresses the Nicotine-Induced Expression of the Matrix Metalloproteinase-9 via Inhibiting ROS-Mediated AP-1 and NF-κB Signaling in Human Gastric Cancer Cells |
- | in-vitro, | GC, | AGS |
2168- | SFN,  |   | Amelioration of Alzheimer's disease by neuroprotective effect of sulforaphane in animal model |
- | in-vivo, | AD, | NA |
3321- | SIL,  |   | cognitive_vitality_media/Silymarin-Cognitive-Vitality-For-Researchers.pdf">Silymarin (Milk thistle) |
- | Review, | AD, | NA |
3319- | SIL,  |   | Silymarin and neurodegenerative diseases: Therapeutic potential and basic molecular mechanisms |
- | Review, | AD, | NA | - | Review, | Park, | NA | - | Review, | Stroke, | NA |
3318- | SIL,  |   | Pharmaceutical prospects of Silymarin for the treatment of neurological patients: an updated insight |
- | Review, | AD, | NA | - | Review, | Park, | NA |
3050- | SK,  |   | Systemic administration of Shikonin ameliorates cognitive impairment and neuron damage in NPSLE mice |
- | in-vivo, | Nor, | NA |
3049- | SK,  |   | Shikonin Attenuates Chronic Cerebral Hypoperfusion-Induced Cognitive Impairment by Inhibiting Apoptosis via PTEN/Akt/CREB/BDNF Signaling |
- | in-vivo, | Nor, | NA | - | NA, | Stroke, | NA |
3432- | TQ,  |   | Thymoquinone: Review of Its Potential in the Treatment of Neurological Diseases |
- | Review, | AD, | NA | - | Review, | Park, | NA |
- | in-vivo, | AD, | NA |
3556- | TQ,  |   | Thymoquinone alleviates the experimentally induced Alzheimer’s disease inflammation by modulation of TLRs signaling |
- | in-vivo, | AD, | NA |
3570- | TQ,  |   | Thymoquinone alleviates the experimentally induced Alzheimer's disease inflammation by modulation of TLRs signaling |
- | in-vivo, | AD, | NA |
3565- | TQ,  |   | Thymoquinone as a potential therapeutic for Alzheimer’s disease in transgenic Drosophila melanogaster model |
3564- | TQ,  |   | The Potential Neuroprotective Effect of Thymoquinone on Scopolamine-Induced In Vivo Alzheimer's Disease-like Condition: Mechanistic Insights |
- | in-vivo, | AD, | NA |
3563- | TQ,  |   | Thymoquinone (TQ) demonstrates its neuroprotective effect via an anti-inflammatory action on the Aβ(1–42)-infused rat model of Alzheimer's disease |
- | in-vivo, | AD, | NA |
3557- | TQ,  |   | Thymoquinone protects against lipopolysaccharides-induced neurodegeneration and Alzheimer-like model in mice. |
- | in-vivo, | AD, | NA |
3560- | TQ,  |   | Protective effects of thymoquinone on D-galactose and aluminum chloride induced neurotoxicity in rats: biochemical, histological and behavioral changes |
- | in-vivo, | AD, | NA |
3559- | TQ,  |   | Molecular signaling pathway targeted therapeutic potential of thymoquinone in Alzheimer’s disease |
- | Review, | AD, | NA | - | Review, | Var, | NA |
3153- | VitC,  |   | Vitamin C Status and Cognitive Function: A Systematic Review |
- | Review, | AD, | NA |
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:557 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid